SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription. FDA Authorizes 2 Rapid, At-Home Coronavirus Tests Imagine waking up, brushing ...
QuidelOrtho Corporation recently expanded its QUICKVUE portfolio with the launch of the QUICKVUE Influenza + SARS Test, a rapid, CLIA-waived immunoassay for professional use that delivers simultaneous ...
WASHINGTON - The U.S. Food and Drug Administration has granted emergency use authorization for another COVID-19 at-home test. The agency approved the Quidel QuickVue At-Home COVID-19 Test, allowing ...
Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Gone are the days of visiting a doctor’s office to determine whether ...
Home collection tests: The test kit prompts you to collect a sample at home (a nose or throat swab) and send it to a lab. The lab then performs a Polymerase Chain Reaction (PCR) test on the sample, ...
QuidelOrtho (QDEL) is expanding its QUICKVUE portfolio with the QUICKVUE Influenza + SARS Test, a CLIA-waived, 510(k)-cleared rapid, easy-to-use immunoassay designed for professional use in physician ...
July 23 (Reuters) - Quidel Corp , which provides rapid diagnostic tests, reported better-than-expected quarterly results, helped by strong performance of its infectious disease diagnostic product line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback